摘要
目的:采用Eudragit RS30D对盐酸伪麻黄碱微丸进行缓释包衣,优化包衣液处方。方法:通过单因素考察,确定影响药物释放的主要因素,以综合评分值(Y)为评价指标,采用中心复合设计试验对包衣液处方进行优化,确立处方组成,并在优化区域内选择一点安排一次验证试验,以检验优化工艺条件的有效性。结果:理论包衣增重(X1)和抗黏剂滑石粉用量(X2)是影响药物释放的主要因素,其中理论包衣增重(X1)对评价指标有非常显著影响(P<0.01),拟合所得多元二次方程为Y=576.2-17.88X1-4.244X2+0.1449X12+0.06391X1X2+0.01080X22,r=0.9775。验证试验表明,本优化方程有良好的预测性。结论:中心复合设计法优化的制备条件良好,制得的盐酸伪麻黄碱缓释微丸的体外累积释放度符合要求。
Objective :To optimize coating solution formulation using Eudragit RS30D and prepare pseudoephedrine hydrochloride sustained-release pellets. Methods:The formulation was developed based on a single-factor test, which was carried out to screen the critical influencing factors for the release rate. The optimal formulations were obtained by a central composite design. Results:The theoretical increment in coating weight (X1) and the anti-adhesive agent talc (X2 ) were the main factors which influenced the release rate. Among the two materials, the theoretical increment in coating weight (X1) affected the release rate more dramatically (P 〈 0.01 ). The correlation equation was Y = 576.2 - 17.88X1 - 4. 244X2 + 0. 144 9X21 + 0. 063 91X1X2 + 0. 010 80X22 and the correlation coefficient was 0. 977 5. Validation results showed that this equation was capable of prediction for optimization of the formulation. Conclusion :The central composite design was able to optimize the coating solution formulation of pseudoephedrine hydrochloride sustained-release pellets.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2007年第16期1275-1279,共5页
Chinese Journal of New Drugs
关键词
中心复合设计
盐酸伪麻黄碱
缓释微丸
丙烯酸树脂
central composite design
pseudoephedrine hydrochloride
sustained-release pellets
Eudragit RS30D